Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | -0% | 8.2% | 15.1% |
| Success rate | 46% | 68% | 82% |
| Transactions |
3
67% Buy
|
34
71% Buy
|
47
69% Buy
|
| Average return | -9% |
|---|---|
| Success rate | 73% |
| Average holding period | 220 |
| Transactions | 28 |
| Position | Company | Period |
|---|---|---|
| Chief Executive Officer | Guard Therapeutics International AB (publ) | Jan. 15, 2019 - |
| Chief Medical Officer | Guard Therapeutics International AB (publ) | Dec. 1, 2018 - Jan. 15, 2019 |
Search
| Notification date | Transaction date | Company | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2022-01-21 | 2022-01-20 | B Purchase |
76,719
449.26
SEK1,333,662 |
76,719 | 449.26 | SEK1,333,662 | ||
| 2022-01-21 | 2022-01-20 | S Sale |
40,185
361.43
SEK3,224,172 |
40,185 | 361.43 | SEK3,224,172 | ||
| 2021-12-02 | 2021-12-01 | B Purchase |
43,932
334.05
SEK2,979,027 |
43,932 | 334.05 | SEK2,979,027 | ||
| 2020-10-03 | 2020-10-02 | B Purchase |
260,673
1.30
SEK338,875 |
260,673 | 1.30 | SEK338,875 | ||
| 2019-02-15 | 2019-02-15 | B Purchase |
500,004
500,004.00
SEK250,004,000,016 |
500,004 | 500,004.00 | SEK250,004,000,016 | ||
| 2019-02-15 | 2019-02-15 | B Purchase |
147,060
0.00
SEK0 |
147,060 | 0.00 | SEK0 | ||
| 2019-02-15 | 2019-02-15 | B Purchase |
49,020
10.20
SEK500,004 |
49,020 | 10.20 | SEK500,004 | ||
| 2019-12-27 | 2019-02-12 | B Purchase |
2,105,263
0.19
SEK400,000 |
2,105,263 | 0.19 | SEK400,000 |